Healthcare

SEQU.BO
NOIN.BO
CLAI.BO

Merck immunotherapy appears effective in head and neck cancer-study

May 29 - A Merck & Co drug that helps the immune system fight cancer was about twice as effective as the current standard therapy for patients with recurrent or advanced head and neck cancers, according to study data released on Friday.

11:30pm IST

Genetic glitch can predict response to new class of cancer drugs

CHICAGO, May 29 - Patients with colon and other cancers who have a specific defect in genes needed for DNA repair are far more likely to respond to a new class of drugs such as Merck & Co's Keytruda, which enlist the immune system to attack tumors, a new study has shown.

11:30pm IST

Bristol's Opdivo reduces risk of death from common lung cancer

Chicago May 29 - Bristol-Myers Squibb Co's drug, Opdivo, improved survival for patients with the most common form of lung cancer, nearly doubling survival for those with high levels of a specific protein in their tumors compared with chemotherapy, according to clinical trial results presented on Friday.

11:30pm IST

UPDATE 1-Health insurer Humana considering selling itself - WSJ

May 29 - Health insurer Humana Inc is considering selling itself and it has received indications of takeover interest, the Wall Street Journal reported, citing sources familiar with the matter.

11:29pm IST

UPDATE 1-Live anthrax found in U.S. military shipment to Australia -official

WASHINGTON, May 29 - An investigation of a U.S. military facility's mistaken shipments of live anthrax bacteria has turned up another live sample, this one from a 2008 batch sent to Australia, a U.S. defense official said on Friday.

11:25pm IST
BSE OIL & GAS +1.32%
BSE BANKEX +1.45%
BSE METALS +0.53%
BSE REALTY -0.13%
BSE AUTO +2.08%
BSE POWER +0.18%
BSE-CG +1.23%

Markets

  • Sectors
  • Asia
  • U.S.
  • Europe

Sector Summary

Photo

Data shows Indian growth outstrips China's but economists doubtful

NEW DELHI - India's economy grew faster than China's in the quarter through March, data showed on Friday, but a sharp downward revision for the previous quarter fuelled doubts about the accuracy of a new method used to measure economic activity.